navigation
total 1504 publications found
filter by journal
| view | year | title | authors |
|---|---|---|---|
| 2025 | Integrase Strand Transfer Inhibitor-Related Changes in Body Mass Index and Risk of Diabetes: A Prospective Study From the RESPOND Cohort Consortium. | Rupasinghe D#Bansi-Matharu L#Law M#Zangerle R#Rauch A#Tarr PE#Greenberg L#Neesgaard B#Jaschinski N#De Wit S#Wit F#d'Arminio Monforte A#Fontas E#Castagna A#Stecher M#Florence E#Begovac J#Mussini C#Sonnerborg A#Abutidze A#Groh A#Vannappagari V#Cohen C#Young L#Hosein S#Ryom L#Petoumenos K#and the Swiss HIV Cohort Study | |
| 2025 | Harmonization of alcohol use data and mortality across a multi-national HIV cohort collaboration. | Ingle SM#Trickey A#Lankina A#McGinnis KA#Justice A#Cavassini M#d' Arminio Monforte A#van Sighem A#Gill MJ#Crane HM#Obel N#Jarrin I#Wallner E#Guest J#Silverberg MJ#Vourli G#Wittkop L#Sterling TR#Satre DD#Burkholder GA#Costagliola D#Sterne JAC#and the Swiss HIV Cohort Study | |
| 2025 | Cannabis Use and Self-Reported Bothersome Symptoms in People with HIV. | Wrona A#Justice AC#Tate JP#Rentsch CT#Gordon KS#Kidwai-Khan F#Silverberg MJ#Satre DD#Marconi VC#Ingle SM#Sterne JAC#Cavassini M#Bryant K#McGinnis KA#and the Swiss HIV Cohort Study | |
| 2025 | Viremia Does Not Independently Predict Cardiovascular Disease in People With HIV: A RESPOND Cohort Study. | Elvstam O#Ryom L#Neesgaard B#Tau L#Gunthard HF#Zangerle R#Vehreschild JJ#Wit F#Sonnerborg A#Kovari H#Abutidze A#Petoumenos K#Jaschinski N#Hosein S#Bogner J#Grabmeier-Pfistershammer K#Garges H#Rooney J#Young L#Law M#Kirk O#and the Swiss HIV Cohort Study | |
| 2025 | Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune function. | Audige A#Amstutz A#Schuurmans MM#Amico P#Braun DL#Stoeckle MP#Hasse B#Hage R#Damm D#Tamm M#Mueller NJ#Gunthard HF#Koller MT#Schonenberger CM#Griessbach A#Labhardt ND#Kouyos RD#Trkola A#Huber M#Kusejko K#Bucher HC#Abela IA#Briel M#Chammartin F#Speich B#and the Swiss HIV Cohort Study | |
| 2025 | Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity. | Foulkes C#Friedrich N#Ivan B#Stiegeler E#Magnus C#Schmidt D#Karakus U#Weber J#Gunthard HF#Pasin C#Rusert P#Trkola A#and the Swiss HIV Cohort Study | |
| 2025 | Late re-engagement into HIV care among adults in the Swiss HIV Cohort Study. | Kusejko K#Cavassini M#Gunthard H#Stockle M#Calmy A#Bernasconi E#Schmid P#Egger M#Wandeler G#Haas AD#and the Swiss HIV Cohort Study | |
| 2024 | Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL'HIV open-label, factorial randomised controlled trial. | Marinosci A#Sculier D#Wandeler G#Yerly S#Stoeckle M#Bernasconi E#Braun DL#Vernazza P#Cavassini M#Buzzi M#Metzner KJ#Decosterd L#Gunthard HF#Schmid P#Limacher A#Branca M#Calmy A#and the Swiss HIV Cohort Study | |
| 2024 | Infectious disease events in people with HIV receiving kidney transplantation: Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study. | Kusejko K#Kouyos RD#Bernasconi E#Boggian K#Braun DL#Calmy A#Cavassini M#van Delden C#Furrer H#Garzoni C#Hirsch HH#Hirzel C#Manuel O#Schmid P#Khanna N#Haidar F#Bonani M#Golshayan D#Dickenmann M#Sidler D#Schnyder A#Mueller NJ#Gunthard HF#Schreiber PW#and the Swiss HIV Cohort Study | |
| 2024 | Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies. | Fernbach S#Mair NK#Abela IA#Groen K#Kuratli R#Lork M#Thorball CW#Bernasconi E#Filippidis P#Leuzinger K#Notter J#Rauch A#Hirsch HH#Huber M#Gunthard HF#Fellay J#Kouyos RD#Hale BG#and the Swiss HIV Cohort Study | |
| 2024 | Weight, anthropometric and metabolic changes after discontinuing antiretroviral therapy containing tenofovir alafenamide (TAF) in people with HIV. | Damas J#Munting A#Fellay J#Haerry D#Marzolini C#Tarr PE#Steffen A#Braun DL#Stoeckle M#Bernasconi E#Nawej Tshikung O#Fux CA#Darling KEA#Beguelin C#Wandeler G#Cavassini M#Surial B#and the Swiss HIV Cohort Study | |
| 2024 | Time Trends in Causes of Death in People with HIV: Insights from the Swiss HIV Cohort Study. | Weber MSR#Duran Ramirez JJ#Hentzien M#Cavassini M#Bernasconi E#Hofmann E#Furrer H#Kovari H#Stockle M#Schmid P#Haerry D#Braun DL#Gunthard HF#Kusejko K#and the Swiss HIV Cohort Study | |
| 2024 | Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration. | Tusch E#Ryom L#Pelchen-Matthews A#Mocroft A#Elbirt D#Oprea C#Gunthard HF#Staehelin C#Zangerle R#Suarez I#Vehreschild JJ#Wit F#Menozzi M#d'Arminio Monforte A#Spagnuolo V#Pradier C#Carlander C#Suanzes P#Wasmuth JC#Carr A#Petoumenos K#Borgans F#Bonnet F#De Wit S#El-Sadr W#Neesgaard B#Jaschinski N#Greenberg L#Hosein SR#Gallant J#Vannappagari V#Young L#Sabin C#Lundgren J#Peters L#Reekie J#and the Swiss HIV Cohort Study | |
| 2024 | HIV-1 low-level viremia predicts viral failure in participants on antiretroviral therapy in the Swiss HIV Cohort Study. | Lanz C#Meier J#Stockle M#Furrer H#Calmy A#Cavassini M#Bernasconi E#Schmid P#Braun DL#Kouyos RD#Loosli T#Kusejko K#Gunthard HF#and the Swiss HIV Cohort Study | |
| 2024 | Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland. | Thoueille P#Saldanha SA#Schaller F#Choong E#Munting A#Cavassini M#Braun D#Gunthard HF#Kusejko K#Surial B#Furrer H#Rauch A#Rougemont M#Ustero P#Calmy A#Stockle M#Marzolini C#Di Benedetto C#Bernasconi E#Schmid P#Piso RJ#Andre P#Girardin FR#Guidi M#Buclin T#Decosterd LA#and the Swiss HIV Cohort Study | |
| 2024 | All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre cohort study. | Kraef C#Tusch E#Singh S#Ostergaard L#Fatkenheuer G#Castagna A#Moreno S#Kusejko K#Szetela B#Kuznetsova A#Tomazic J#Ranin J#Zangerle R#Mansson F#Marchetti G#De Wit S#Clarke A#Gerstoft J#Podlekareva D#Peters L#Reekie J#Kirk O#and the Swiss HIV Cohort Study | |
| 2024 | Transcriptional profile of Mycobacterium tuberculosis infection in people living with HIV. | Tepekule B#Jorimann L#Schenkel CD#Opitz L#Tschumi J#Wolfensberger R#Neumann K#Kusejko K#Zeeb M#Boeck L#Kalin M#Notter J#Furrer H#Hoffmann M#Hirsch HH#Calmy A#Cavassini M#Labhardt ND#Bernasconi E#Oesch G#Metzner KJ#Braun DL#Gunthard HF#Kouyos RD#Duffy F#Nemeth J#and the Swiss HIV Cohort Study | |
| 2024 | Self-reported neurocognitive complaints in the Swiss HIV Cohort Study: a viral genome-wide association study. | Zeeb M#Pasin C#Cavassini M#Bieler-Aeschlimann M#Frischknecht P#Kusejko K#Fellay J#Blanquart F#Metzner KJ#Neumann K#Jorimann L#Tschumi J#Bernasconi E#Huber M#Kovari H#Leuzinger K#Notter J#Perreau M#Rauch A#Ramette A#Stockle M#Yerly S#Gunthard HF#Kouyos RD#and the Swiss HIV Cohort Study | |
| 2024 | Cohort profile: the Swiss Mother and Child HIV Cohort Study (MoCHiV). | Paioni P#Capaul M#Brunner A#Traytel A#Aebi-Popp K#Crisinel PA#Duppenthaler A#Gunthard H#Martinez De Tejada B#Kottanattu L#Stockle M#Rauch A#Wagner N#Hosli I#Rudin C#Scherrer A#Kusejko K#Kahlert CR#and the Swiss HIV Cohort Study | |
| 2024 | Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines. | Schwarzmuller M#Lozano C#Schanz M#Abela IA#Grosse-Holz S#Epp S#Curcio M#Greshake J#Rusert P#Huber M#Kouyos RD#Gunthard HF#Trkola A#and the Swiss HIV Cohort Study | |
| 2024 | Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4(+) decline. | Baxter J#Villabona-Arenas CJ#Thompson RN#Hue S#Regoes RR#Kouyos RD#Gunthard HF#Albert J#Leigh Brown A#Atkins KE#and the Swiss HIV Cohort Study | |
| 2024 | Care interruptions and mortality among adults in Europe and North America. | Trickey A#Zhang L#Rentsch CT#Pantazis N#Izquierdo R#Antinori A#Leierer G#Burkholder G#Cavassini M#Palacio-Vieira J#Gill MJ#Teira R#Stephan C#Obel N#Vehreschild JJ#Sterling TR#Van Der Valk M#Bonnet F#Crane HM#Silverberg MJ#Ingle SM#Sterne JAC#and the Swiss HIV Cohort Study | |
| 2024 | Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV. | Thoueille P#Saldanha SA#Schaller F#Choong E#Veuve F#Munting A#Cavassini M#Braun D#Gunthard HF#Duran Ramirez JJ#Surial B#Furrer H#Rauch A#Ustero P#Calmy A#Stockle M#Di Benedetto C#Bernasconi E#Schmid P#Marzolini C#Girardin FR#Buclin T#Decosterd LA#Guidi M#and the Swiss HIV Cohort Study | |
| 2024 | Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3). | Amstutz A#Chammartin F#Audige A#Eichenberger AL#Braun DL#Amico P#Stoeckle MP#Hasse B#Papadimitriou-Olivgeris M#Manuel O#Bongard C#Schuurmans MM#Hage R#Damm D#Tamm M#Mueller NJ#Rauch A#Gunthard HF#Koller MT#Schonenberger CM#Griessbach A#Labhardt ND#Kouyos RD#Trkola A#Kusejko K#Bucher HC#Abela IA#Briel M#Speich B#and the Swiss HIV Cohort Study | |
| 2024 | Deciphering factors linked with reduced SARS-CoV-2 susceptibility in the Swiss HIV Cohort Study. | Abela IA#Hauser A#Schwarzmuller M#Pasin C#Kusejko K#Epp S#Cavassini M#Battegay M#Rauch A#Calmy A#Notter J#Bernasconi E#Fux CA#Leuzinger K#Perreau M#Ramette A#Gottschalk J#Schindler E#Wepf A#Marconato M#Manz MG#Frey BM#Braun DL#Huber M#Gunthard HF#Trkola A#Kouyos RD#and the Swiss HIV Cohort Study |